Home Nephrotoxicity of sodium valproate and protective role of L-cysteine in rats at biochemical and histological levels
Article
Licensed
Unlicensed Requires Authentication

Nephrotoxicity of sodium valproate and protective role of L-cysteine in rats at biochemical and histological levels

  • Nahla S. El-Shenawy EMAIL logo and Reham Z. Hamza
Published/Copyright: April 28, 2016

Abstract

Background:

This study investigated whether the combination of sodium valproate (SV) with L-cysteine (LC) can decrease the SV toxicity of kidneys. SV caused alternation in oxidative/antioxidant balance.

Methods:

Biochemical estimations included the determination of oxidative stress markers like thiobarbituric acid-reactive substances in kidney tissue, and enzymatic antioxidant activities such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase as well as total antioxidant capacity were evaluated in renal tissues. Creatinine and uric acid levels in the serum were also determined to assess kidney function. Pathological examination of the kidney was also performed.

Results:

Increasing the levels of lipid peroxidation and decreasing the enzymatic activity (SOD, CAT, and GPx) as well as total antioxidant capacity of rats was shown with different doses of SV. Impairment in renal function tests suggests a decreased glomerular filtration rate, as serum creatinine was elevated. Histopathological changes of kidney tissue treated with SV reveal the proximal and the distal convoluted tubules that show hydropic changes (small white vacuoles within the cytoplasm and the glomeruli show hypercellularity).

Conclusions:

The concurrent administration of LC with SV significantly had beneficial effects on the kidney and all the above parameters have been improved.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Rodriguez R, Veltri RW. Valproic acid causes dose-and time dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo. Mol Cancer Ther 2009;8:802–8.10.1158/1535-7163.MCT-08-1076Search in Google Scholar PubMed PubMed Central

2. Toktam F, Aghihi A, Jahed J, Mahmoudi V, Sharifi SA, Padideh G. Role of omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial. DARU J Pharm Sci 2012;20:43.10.1186/2008-2231-20-43Search in Google Scholar PubMed PubMed Central

3. Hamza RZ, Ismail HA, Khaled HE, El-Shenawy NS. Antioxidant effect of L-cysteine on sodium valproate-induced oxidative stress in rats’ liver: biochemical and ultrastructure approaches. Toxicol Environ Chem 2015;97:1041–56.10.1080/02772248.2015.1077961Search in Google Scholar

4. Silva MF, Aires CC, Luis PB, Ruiter JP, IJlst L, Duran M. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J Inherit Metab Dis 2008;31:205–16.10.1007/s10545-008-0841-xSearch in Google Scholar PubMed

5. Verrotti A, Greco R, Latini G, Chiarelli F. Endocrine and metabolic changes in epileptic patients receiving valproic acid. J Pediatr Endocrinol Metab 2005;18:423–30.10.1515/JPEM.2005.18.5.423Search in Google Scholar PubMed

6. Zhang M, Wang Y, Wang X-Ch. Valproic acid reduces the ability of neutrophils to fight infection in epileptic patients. Biosci Hypotheses 2009;2:316–8.10.1016/j.bihy.2009.05.005Search in Google Scholar

7. Marson T, Sills G. Valproate. In: The treatment of epilepsy. Chichester, UK: John Wiley & Sons Ltd, 2016:652–66.10.1002/9781118936979.ch51Search in Google Scholar

8. Hussein RR, Soliman RH, Abdelhaleem AM, Tawfeik MH, Abdelrahim ME. Effect of antiepileptic drugs on liver enzymes. Beni-Suef University J Basic Appl Sci 2013;2:14–9.10.1016/j.bjbas.2013.09.002Search in Google Scholar

9. Eskandari S, Arshosaz JV, Minaiyan M, Tabbakhian M. Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. Int J Nanomed 2011;6:363–71.10.2147/IJN.S15881Search in Google Scholar PubMed PubMed Central

10. Hamza RZ, El-Shenawy NS, Ismail HA. Protective effects of blackberry and quercetin on sodium fluoride-induced oxidative stress and histological changes in the hepatic, renal, testis and brain tissue of male rat. J Basic Clin Physiol Pharmacol 2015;26:237–51.10.1515/jbcpp-2014-0065Search in Google Scholar PubMed

11. Bairy L, Paul V, Rao Y. Reproductive toxicity of sodium valproate in male rats. Indian J Pharmacol 2010;42:90–4.10.4103/0253-7613.64503Search in Google Scholar PubMed PubMed Central

12. Khaled HE, Hamza RZ, El-Shenawy NS. Effect of L-cysteine on sodium valproate induced testicular alterations in rats. Intern. J. Pathol. 2015. In Press.Search in Google Scholar

13. Dröge W. Oxidative stress and aging: is aging a cysteine deficiency syndrome? Phil Trans R Soc Lond B Biol Sci 2005;360:2355–72.10.1098/rstb.2005.1770Search in Google Scholar PubMed PubMed Central

14. Elshorbagy AK, Nurk E, Gjesdal CG, Tell GS, Ueland PM. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? Am J Clin Nutr 2008;88:738–46.10.1093/ajcn/88.3.738Search in Google Scholar PubMed

15. Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 2005;2:38–44.10.1186/1550-2783-2-2-38Search in Google Scholar PubMed PubMed Central

16. Jain S, McGinnes LW, Morrison TG. Role of thiol/disulfide exchange in Newcastle disease virus entry. J Virol 2009;83:241–9.10.1128/JVI.01407-08Search in Google Scholar PubMed PubMed Central

17. Alturfan EI, Beceren A, Şehirli AÖ, Demiralp ZE, Şener G, Omurtag GZ. Protective effect of N-acetyl-LC against acrylamide-induced oxidative stress in rats. Turk J Vet Anim Sci 2012;36:438–45.10.3906/vet-1105-29Search in Google Scholar

18. El-Shenawy NS, Al-Ghamdi OA. Phenthoate induced-oxidative stress in fresh isolated mice hepatocytes: alleviation by ascorbic acid. Toxicol Environ Health Sci 2014;6:67–80.10.1007/s13530-014-0190-0Search in Google Scholar

19. El-Shenawy NS, Al-Dahasy AF. Status of oxidative stress/antioxidant system with aqueous ginger extract during potassium bromate toxicity. J Free Rad Antioxid Photon 2013;139:210–25.Search in Google Scholar

20. Khan S, Ahmad T, Parekh CV, Trivedi PP, Kushwaha S, Jena G. Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice. Reprod Toxicol 2011;32:385–94.10.1016/j.reprotox.2011.09.007Search in Google Scholar PubMed

21. Ahmed EA, Omar MA, Abdelghaffar SK, Ragb SM, Nasser AY. The antioxidant activity of vitamin C, DPPD and LC against cisplatin-induced testicular oxidative damage in rats. Food Chem Toxicol 2011;49:1115–21.10.1016/j.fct.2011.02.002Search in Google Scholar PubMed

22. Boussarie D. Hematology of company rodents and lagomorphs. Bull Acad Vet Fr 1999;72:209–16 (in French).Search in Google Scholar

23. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–8.10.1016/0003-2697(79)90738-3Search in Google Scholar

24. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469–74.10.1111/j.1432-1033.1974.tb03714.xSearch in Google Scholar

25. Aebi H. Catalase in vitro. Meth Enzymol 1984;105:121–6.10.1016/S0076-6879(84)05016-3Search in Google Scholar

26. Hafeman DG, Sunde RA, Hoekstra WG. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr 1974;104:580–7.10.1093/jn/104.5.580Search in Google Scholar PubMed

27. Couri D, Abdel-Rahman MS. Effect of chlorine dioxide and metabolites on glutathione-dependent system in rat, mouse and chicken blood. J Environ Pathol Toxicol 1980;3:451–60.Search in Google Scholar

28. Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex specific application to the determination of vitamin E. Anal Biochem 1999;269:337–41.10.1006/abio.1999.4019Search in Google Scholar PubMed

29. Gabe M. Techniques histologiques [Histological Techniques]. Paris: Masson Publisher, 1968.Search in Google Scholar

30. Lobenhofer EK, Boorman GA, Phillips KL, Heinloth AN, Malarkey DE, Blackshear PE. Application of visualization tools to the analysis of histopathological data enhances biological insight and interpretation. Toxicol Pathol 2006;34:921–8.10.1080/01926230601072319Search in Google Scholar PubMed

31. Tabatabaei AR, Abbott FS. Assessing the mechanism of metabolism-dependent valproic acid-induced in vitro cytotoxicity. Chem Res Toxicol 1999;12:323–30.10.1021/tx9801864Search in Google Scholar PubMed

32. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant and radical causes aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981;78:6858–62.10.1073/pnas.78.11.6858Search in Google Scholar PubMed PubMed Central

33. Barone JM, Frezzatti R, Silveira PF. Effects of N-acetyl-l-cysteine on redox status and markers of renal function in mice inoculated with Bothrops jararaca and Crotalus durissus terrificus venoms. Toxicon 2014;79:1–10.10.1016/j.toxicon.2013.12.010Search in Google Scholar PubMed

34. Hovinga CA, Chicella MF, Rose DF, Eades SK, Dalton JT, Phelps SJ. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother. 1999;33:579–84.10.1345/aph.18349Search in Google Scholar PubMed

35. Hergüner MO, Altunbaşak S, Doğan A, Yildizdaş D, Incecik F, Erdoğan S, et al. Effects of sodium valproate on renal functions in rats. Ren Fail 2006;28:593–7.10.1080/08860220600843821Search in Google Scholar

36. Olson MJ, Handler JA, Thurman RG. Mechanism of zone specific hepatic steatosis caused by valproate: inhibition of ketogenesis in periportal regions of the liver lobule. Mol Pharmacol 1996;30:520–25.10.1016/S0026-895X(25)10413-6Search in Google Scholar

37. Kassahun K, Hu M, Grillo MR, Davis LJ, Baillie TA. Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes. Chem Biol Interact 1994;90:253–74.10.1016/0009-2797(94)90014-0Search in Google Scholar

38. Rittle J, Green MT. Cytochrome P450 compound I: capture, characterization, and C-H bond activation kinetics. Science 2010;330:933–7.10.1126/science.1193478Search in Google Scholar PubMed

39. Turnbull DM, Dick DJ, Wilson L, Sherratt HS, Alberti KG. Valproate causes metabolic disturbances in normal man. J Neurol Neurosurg Psychiatry 1986;49:405–40.10.1136/jnnp.49.4.405Search in Google Scholar PubMed PubMed Central

40. Amel AZ, Djamila B, Nassima B, Ouahiba M, Zahia B, Fadila B, et al. The protective effect of Chrysanthemum fantanesii extract, vitamin E and C on sodium valproate-induced embryotoxicity in pregnant mice. Med Plants Res 2012;6:3535–44.10.5897/JMPR11.1060Search in Google Scholar

41. Baker DH, Czarnecki-Maulden GL. Pharmacologic role of cysteine in ameliorating or exacerbating mineral toxicities. J Nutr 1987;117:1003–10.10.1093/jn/117.6.1003Search in Google Scholar PubMed

42. Katayama R, Nagata S, Iida H, Yamagishi N, Yamashita T, Furuhama K. Possible role of cysteine-S-conjugate b-lyase in species differences in cisplatin nephrotoxicity. Food Chem Toxicol 2011;49:2053–9.10.1016/j.fct.2011.05.017Search in Google Scholar PubMed

43. Stern ST, Bruno MK, Hennig GE, Horton RA, Roberts JC, Cohen SD. Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity in CD-1 mice: I. Enhancement of acetaminophen nephrotoxicity by acetaminophen-cysteine. Toxicol Appl Pharmacol 2005;202:151–9.10.1016/j.taap.2004.06.030Search in Google Scholar PubMed

44. Tong V, Thomas KH, Frank S. Valproic acid: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats. Toxicol Sci 2005;86:427–35.10.1093/toxsci/kfi184Search in Google Scholar PubMed

45. Spiller HA, Krenzelok EP, Klein-Schwartz W, Winter ML, Webe JA, Sollee DR. Multicenter case series of valproic acid ingestion: serum concentrations and toxicity. J Toxicol Clin Toxicol 2000;38:755–60.10.1081/CLT-100102388Search in Google Scholar

Received: 2015-9-6
Accepted: 2016-2-26
Published Online: 2016-4-28
Published in Print: 2016-9-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2015-0106/html
Scroll to top button